Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
์ข
๋ชฉ ์ฝ๋ AKYA
ํ์ฌ ์ด๋ฆAkoya Biosciences Inc
์์ฅ์ผApr 16, 2021
CEOMr. Brian Mckelligon
์ง์ ์205
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃApr 16
์ฃผ์100 Campus Drive
๋์MARLBOROUGH
์ฆ๊ถ ๊ฑฐ๋์NASDAQ Global Select Consolidated
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ01762
์ ํ18558968401
์น์ฌ์ดํธhttps://www.akoyabio.com/
์ข
๋ชฉ ์ฝ๋ AKYA
์์ฅ์ผApr 16, 2021
CEOMr. Brian Mckelligon
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์